MyAverix Finance
TA · Healthcare
Bonus Biogroup (BONS)
Biotechnology
Bonus Biogroup (BONS) is listed on TA in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BONS
Bonus Biogroup (BONS) — FAQ
What is BONS's P/E ratio?
The price-to-earnings (P/E) ratio for Bonus Biogroup (BONS) is 25.00 (data as of 2026-05-24).
Does Bonus Biogroup pay a dividend?
Dividend yield is not available in the current snapshot for Bonus Biogroup (BONS). Check the MyAverix Finance app for the latest dividend data.
What sector is Bonus Biogroup in?
Bonus Biogroup (BONS) is classified in the Healthcare sector (Biotechnology industry).
What exchange is BONS listed on?
BONS is listed on TA.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.